The Manufacturers Life Insurance Company Raises Stock Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

The Manufacturers Life Insurance Company boosted its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 6.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,464 shares of the semiconductor company’s stock after purchasing an additional 1,097 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.06% of Axcelis Technologies worth $2,768,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of ACLS. GAMMA Investing LLC lifted its position in shares of Axcelis Technologies by 109.4% in the first quarter. GAMMA Investing LLC now owns 266 shares of the semiconductor company’s stock valued at $30,000 after acquiring an additional 139 shares in the last quarter. Signaturefd LLC lifted its position in shares of Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after acquiring an additional 164 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Axcelis Technologies by 223.8% in the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after acquiring an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in shares of Axcelis Technologies in the second quarter valued at approximately $39,000. Finally, Isthmus Partners LLC lifted its position in shares of Axcelis Technologies by 87.3% in the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock valued at $47,000 after acquiring an additional 15,507 shares in the last quarter. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Insiders Place Their Bets

In other Axcelis Technologies news, Director Jorge Titinger sold 6,086 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total transaction of $669,338.28. Following the completion of the sale, the director now owns 5,891 shares of the company’s stock, valued at $647,892.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.43% of the stock is owned by insiders.

Axcelis Technologies Price Performance

ACLS stock opened at $98.50 on Wednesday. The business has a fifty day moving average of $106.21 and a two-hundred day moving average of $115.52. The company has a quick ratio of 3.26, a current ratio of 4.42 and a debt-to-equity ratio of 0.05. The stock has a market cap of $3.20 billion, a price-to-earnings ratio of 13.01, a price-to-earnings-growth ratio of 3.09 and a beta of 1.58. Axcelis Technologies, Inc. has a 52-week low of $93.77 and a 52-week high of $170.97.

Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Wednesday, July 31st. The semiconductor company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.18. The company had revenue of $256.51 million during the quarter, compared to analysts’ expectations of $250.06 million. Axcelis Technologies had a return on equity of 27.35% and a net margin of 21.54%. The firm’s quarterly revenue was down 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.86 earnings per share. As a group, research analysts anticipate that Axcelis Technologies, Inc. will post 6.05 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ACLS. DA Davidson raised their target price on Axcelis Technologies from $150.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, July 15th. Benchmark cut their price target on Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating for the company in a report on Friday, August 2nd. Bank of America increased their price target on Axcelis Technologies from $125.00 to $150.00 and gave the company a “neutral” rating in a report on Wednesday, July 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a report on Friday, August 2nd. Finally, Craig Hallum increased their price target on Axcelis Technologies from $130.00 to $174.00 and gave the company a “buy” rating in a report on Friday, July 12th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Axcelis Technologies currently has an average rating of “Moderate Buy” and an average price target of $167.33.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.